NUZ 6.25% 22.5¢ neurizon therapeutics limited

PHARMAUST ALL SET FOR ELY LILLY T/O, page-140

  1. 1,463 Posts.
    lightbulb Created with Sketch. 1194
    When Eli Lily became the owner of the patent on MPL as the result of a take over of Pfizer, I think, PAA already had the global patents on MPL for use on the mTOR pathways.
    And I agree with Bakey $20 pffft.. worth a heap more than that!
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.